2648969-30-4
Chemical Structure
ATX inhibitor 10
- CAS No.: 2648969-30-4
- Formula:C23H20F3N9O2
- Molecular Weight:511.46
IUPAC Name: (R)-1-(3,4,6,7-tetrahydro-5H-[1,2,3]triazolo[4,5-c]pyridin-5-yl)-2-(5-(2-((5-(trifluoromethyl)-2,3-dihydro-1H-inden-2-yl)amino)pyrimidin-5-yl)-1,3,4-oxadiazol-2-yl)ethan-1-one
InChIKey: MLXSHVIPLIJWTO-MRXNPFEDSA-N
SMILES: FC(C1=CC2=C(C[C@@H](NC3=NC=C(C4=NN=C(CC(N5CCC(N=NN6)=C6C5)=O)O4)C=N3)C2)C=C1)(F)F
Biological Activity: ATX inhibitor 10 is a potent inhibitor of ATX. ATX inhibitor 10 is s nitrogen-containing heterocyclic compound. ATX plays a role in causing pathological conditions including fibrosis, arthritis, neurodegeneration, neuropathic pain, and cancer. ATX inhibitor 10 has the potential for the research of ATX related diseases (extracted from patent WO2021115375A1, compound 35)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
ATX inhibitor 10 | ATX inhibitor 10 is a potent inhibitor of ATX. ATX inhibitor 10 is s nitrogen-containing heterocyclic compound. ATX plays a role in causing pathological conditions including fibrosis, arthritis, neurodegeneration, neuropathic pain, and cancer. ATX inhibitor 10 has the potential for the research of ATX related diseases (extracted from patent WO2021115375A1, compound 35). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
